Andreas Halvorsen's BBIO Position
BRIDGEBIO PHARMA INC — 20 quarters of data (Q1 2021 to Q4 2025)
Current Shares
14.39M
Current Value
$1.10B
Peak Shares
26.62M
Q1 2021
Overall Change
-46%
Shares Over Time
Q1 2021
26.62M
Q2 2021
26.62M
0%
Q3 2021
26.62M
0%
Q4 2021
26.62M
0%
Q1 2022
26.62M
0%
Q2 2022
26.62M
0%
Q3 2022
26.62M
0%
Q4 2022
26.62M
0%
Q1 2023
26.62M
0%
Q2 2023
26.62M
0%
Q3 2023
25.12M
-6%
Q4 2023
25.12M
0%
Q1 2024
25.12M
0%
Q2 2024
25.12M
0%
Q3 2024
25.12M
0%
Q4 2024
25.12M
0%
Q1 2025
22.06M
-12%
Q2 2025
18.56M
-16%
Q3 2025
0
-100%
Q4 2025
14.39M
+100%
Quarterly Detail
| Quarter | Shares | Value | $/Share | Change | Shares Δ |
|---|---|---|---|---|---|
| Q4 2025 2026-02-17 | 14.39M | $1.10B | $76.49 | +100% | +14.39M |
| Q3 2025 2025-11-14 | SOLD | - | - | -100% | -18,555,375 |
| Q2 2025 2025-08-14 | 18.56M | $801.22M | $43.18 | -16% | -3,500,000 |
| Q1 2025 2025-05-15 | 22.06M | $762.45M | $34.57 | -12% | -3,065,616 |
| Q4 2024 2025-02-14 | 25.12M | $689.32M | $27.44 | 0% | 0 |
| Q3 2024 2024-11-14 | 25.12M | $639.58M | $25.46 | 0% | 0 |
| Q2 2024 2024-08-14 | 25.12M | $636.32M | $25.33 | 0% | 0 |
| Q1 2024 2024-05-15 | 25.12M | $776.74M | $30.92 | 0% | 0 |
| Q4 2023 2024-02-14 | 25.12M | $1014.13B | $40370.00 | 0% | 0 |
| Q3 2023 2023-11-14 | 25.12M | $662.44B | $26370.00 | -6% | -1,500,000 |
| Q2 2023 2023-08-14 | 26.62M | $457.88B | $17200.00 | 0% | 0 |
| Q1 2023 2023-05-15 | 26.62M | $441.38B | $16580.00 | 0% | 0 |
| Q4 2022 2023-02-14 | 26.62M | $202.85M | $7.62 | 0% | 0 |
| Q3 2022 2022-11-14 | 26.62M | $264.61M | $9.94 | 0% | 0 |
| Q2 2022 2022-08-15 | 26.62M | $241.72M | $9.08 | 0% | 0 |
| Q1 2022 2022-05-16 | 26.62M | $270.20M | $10.15 | 0% | 0 |
| Q4 2021 2022-05-16 | 26.62M | $444.04M | $16.68 | 0% | 0 |
| Q3 2021 2022-05-16 | 26.62M | $1.25B | $46.87 | 0% | 0 |
| Q2 2021 2021-08-16 | 26.62M | $1.62B | $60.96 | 0% | 0 |
| Q1 2021 2021-05-17 | 26.62M | $1.64B | $61.60 | New | - |